Published in BMC Cancer on January 15, 2010
MAP Kinases and Prostate Cancer. J Signal Transduct (2011) 1.06
Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway. Oncotarget (2014) 1.00
Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer. Prostate Cancer (2013) 0.94
Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett (2013) 0.92
Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene. J Biomed Sci (2014) 0.84
Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70-Bax interaction in prostate cancer. Apoptosis (2014) 0.80
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy. Springerplus (2016) 0.79
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia. Int J Mol Sci (2016) 0.75
Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy. BMC Cancer (2015) 0.75
Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies? Front Pharmacol (2017) 0.75
Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma. Int J Mol Sci (2016) 0.75
Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study. Int J Mol Sci (2017) 0.75
IAP family proteins--suppressors of apoptosis. Genes Dev (1999) 9.96
Caspases: intracellular signaling by proteolysis. Cell (1997) 7.46
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell (1995) 5.50
The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene (1998) 3.98
Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther (2006) 2.55
Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res (2004) 2.19
Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology (2000) 2.15
NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? J Cell Biochem (2004) 1.85
Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res (2003) 1.83
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol (2001) 1.78
Survivin mediates resistance to antiandrogen therapy in prostate cancer. Oncogene (2005) 1.68
Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med (1999) 1.58
NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer. Mol Cell Biol (2002) 1.55
Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol (1999) 1.53
Survivin expression is associated with features of biologically aggressive prostate carcinoma. Cancer (2004) 1.41
X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther (2004) 1.36
cIAP1, cIAP2, and XIAP act cooperatively via nonredundant pathways to regulate genotoxic stress-induced nuclear factor-kappaB activation. Cancer Res (2009) 1.34
The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc (2001) 1.24
Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family. Mol Cell Biol (2001) 1.23
The p38 transduction pathway in prostatic neoplasia. J Pathol (2006) 1.17
Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate (2002) 1.15
Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. J Urol (2004) 1.14
Genomic organization of the X-linked inhibitor of apoptosis and identification of a novel testis-specific transcript. Genomics (2001) 1.11
NF-kappaB-mediated IAP expression induces resistance of intestinal epithelial cells to apoptosis after polyamine depletion. Am J Physiol Cell Physiol (2003) 1.09
Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum Pathol (2005) 1.05
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes. Cancer Res (2003) 1.02
TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate. Histol Histopathol (2008) 1.01
Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol (2004) 0.99
Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J Urol (2005) 0.99
Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol (2001) 0.98
Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate. Hum Pathol (2002) 0.98
The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition. Biochem J (2005) 0.97
Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer (2006) 0.93
Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol (1999) 0.91
Expression of IAP family proteins in colon cancers from patients with different age groups. Cancer Immunol Immunother (2004) 0.88
Distribution of neuronal apoptosis inhibitory protein in human tissues. J Histochem Cytochem (2007) 0.87
Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer. J Korean Med Sci (2007) 0.85
TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma). Histopathology (2008) 0.85
Immunoexpression of tumour necrosis factor-alpha and its receptors 1 and 2 correlates with proliferation/apoptosis equilibrium in normal, hyperplasic and carcinomatous human prostate. Cytokine (2000) 0.83
IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis. Growth Factors (2000) 0.82
Survivin and Bcl-2 expression in prostatic adenocarcinomas. Arch Pathol Lab Med (2004) 0.82
Identification of two distinct transcripts for the neuronal apoptosis inhibitory protein gene. Biochem Biophys Res Commun (1999) 0.79
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science (2003) 3.19
Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate (2003) 1.73
The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. Gut (2010) 1.45
Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. J Pathol (2004) 1.23
MAP Kinases and Prostate Cancer. J Signal Transduct (2011) 1.06
Nestin, a neuroectodermal stem cell marker molecule, is expressed in Leydig cells of the human testis and in some specific cell types from human testicular tumours. Cell Tissue Res (2004) 1.04
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates. Transplantation (2005) 1.04
Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys. Xenotransplantation (2004) 0.99
Regulation of proliferation/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate. Hum Pathol (2002) 0.98
Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer (2007) 0.96
Ability to grow on lipids accounts for the fully virulent phenotype in neutropenic mice of Aspergillus fumigatus null mutants in the key glyoxylate cycle enzymes. Fungal Genet Biol (2007) 0.95
Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma. Cancer (2004) 0.95
Role of tumor necrosis factor-alpha and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Sci (2006) 0.94
Bilateral prepubertal testicular biopsies predict significance of cryptorchidism-associated mixed testicular atrophy, and allow assessment of fertility. Am J Surg Pathol (2007) 0.89
Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer. Cancer Detect Prev (2008) 0.89
Glucocorticoid receptor changes its cellular location with breast cancer development. Histol Histopathol (2008) 0.88
Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer. Cytokine (2013) 0.87
Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha. BMC Cancer (2008) 0.87
Deregulated expression of the PCPH proto-oncogene in human breast cancers. Int J Oncol (2004) 0.87
DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status. Breast Cancer Res (2004) 0.85
Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells. Prostate (2011) 0.84
Overexpression of troponin T in Drosophila muscles causes a decrease in the levels of thin-filament proteins. Biochem J (2005) 0.84
Normal and pathological human testes express hormone-sensitive lipase and the lipid receptors CLA-1/SR-BI and CD36. Hum Pathol (2004) 0.83
Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors. Hum Pathol (2011) 0.82
OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative). Cancer Invest (2008) 0.82
Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study. Breast Cancer Res (2003) 0.82
Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland. Eur Cytokine Netw (2010) 0.82
Control of the annual testicular cycle of the marbled-newt by p53, p21, and Rb gene products. Mol Reprod Dev (2002) 0.81
Pro-apoptotic tumor necrosis factor-alpha transduction pathway in normal prostate, benign prostatic hyperplasia and prostatic carcinoma. J Urol (2003) 0.81
The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels. Inflammation (2009) 0.80
Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain. AIDS Res Hum Retroviruses (2012) 0.78
Calponin, caldesmon, and chromatophores: The smooth muscle connection. Microsc Res Tech (2002) 0.78
Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy. World J Urol (2014) 0.78
Ultrastructural staining with sodium metaperiodate and sodium borohydride. J Histochem Cytochem (2002) 0.77
Immunohistochemical detection of the retinoid X receptors alpha, beta, and gamma in human prostate. J Androl (2003) 0.77
Perspectives in pediatric pathology, chapter 3. Testicular development from birth to puberty: systematic evaluation of the prepubertal testis. Pediatr Dev Pathol (2014) 0.76
Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914. Xenotransplantation (2004) 0.76
Focal orchitis in undescended testes: discussion of pathogenetic mechanisms of tubular atrophy. Arch Pathol Lab Med (2002) 0.76
Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma. Br J Haematol (2012) 0.76
Diagnostic value of differential quantification of spermatids in obstructive azoospermia. J Androl (2003) 0.75
Anti-pig antibody levels in non-human primates of various origin. Xenotransplantation (2004) 0.75
Cloning of the cDNA and mRNA expression of CLRP, a complex leucine repeat protein of the Golgi apparatus expressed by specific neurons of the rat brain. J Neurobiol (2002) 0.75
Perspectives in pediatric pathology, chapter 1. Normal development of testicular structures: from the bipotential gonad to the fetal testis. Pediatr Dev Pathol (2014) 0.75
Perspectives in pediatric pathology, chapter 4. Pubertal and adult testis. Pediatr Dev Pathol (2015) 0.75
Perspectives in pediatric pathology: chapter 2. Testicular descent. Pediatr Dev Pathol (2014) 0.75